Invention Grant
- Patent Title: Anti-PfRH5 antibodies and antigen-binding fragments thereof
-
Application No.: US17041595Application Date: 2019-03-22
-
Publication No.: US11667701B2Publication Date: 2023-06-06
- Inventor: Lisa Purcell
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Schwabe, Williamson & Wyatt PC
- Agent Gabe Amodeo
- International Application: PCT/US2019/023734 2019.03.22
- International Announcement: WO2019/190931A 2019.10.03
- Date entered country: 2020-09-25
- Main IPC: C07K16/20
- IPC: C07K16/20 ; A61K9/00 ; A61K39/015
Abstract:
The present invention includes antibodies and antigen-binding fragments thereof that specifically bind to Plasmodium falciparum reticulocyte binding protein homologue 5 (PfRH5), compositions thereof and methods of making such antibodies, fragments and compositions. Method and compositions for treating, preventing or diagnosing Plasmodium falciparum infection and malaria are also part of the present invention.
Public/Granted literature
- US20210024625A1 Anti-PfRH5 Antibodies and Antigen-Binding Fragments Thereof Public/Granted day:2021-01-28
Information query
